CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT)

AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

ACTION:

Notice of meeting.

SUMMARY:

In accordance with the Federal Advisory Committee Act, the CDC and the Health Resources and Services Administration (HRSA), announces the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is open to the public, limited only by audio and web conference lines (1,000 audio and web conference lines are available). The public is welcome to listen to the meeting by accessing the telephone number 1-669-254-5252, and the passcode is 47035054 (1,000 lines are available). The web conference access is https://cdc.zoomgov.com/j/1617148601?pwd=eVBTM0dweHFxQUxWUzU2OEttY1R1QT09,, webinar ID: 161 714 8601 and passcode: v08w0@e5.

DATES:

The meeting will be held on April 20, 2021, from 1:00 p.m. to 5:00 p.m., EDT and April 21, 2021, from 1:00 p.m. to 5:00 p.m., EDT.

ADDRESSES:

The teleconference access is 1-669-254-5252, and the passcode is 47035054. The web conference access is https://cdc.zoomgov.com/j/ ,1617148601?pwd=eVBTM0dweHFxQUxWUzU2OEttY1R1QT09,, webinar ID: 161 714 8601, and passcode: v08w0@e5.

FOR FURTHER INFORMATION CONTACT:

Staci Morris, Committee Management Specialist, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 30329-4027, Telephone: (404) 718-7479; smorris4@cdc.gov.

SUPPLEMENTARY INFORMATION:

Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below by Monday, April 19, 2021. Persons who desire to make an oral statement, may request it at the time of the public comment period on April 20, 2021 at 4:25 p.m., EDT.

Purpose: This committee is charged with advising the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV, Viral Hepatitis and other STDs, the support of health care services to persons living with HIV, and education of health professionals and the public about HIV, Viral Hepatitis and other STDs.

Matters To Be Considered: The agenda will include discussions on (1) STI Screening and Diagnostics; (2) Innovation and COVID-19; and (3) Youth and Mental Health. Agenda items are subject to change as priorities dictate.

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.